Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy
Brief description of study
The purpose of this research study is to identify factors that can predict how patients with idiopathic generalized epilepsy will do on a given seizure medication, whether they will have side effects, and whether they will have more seizures. These factors are called biomarkers. Biomarkers are an indicator of a disease or pathology.
Clinical Study Identifier: s19-01030
ClinicalTrials.gov Identifier: NCT05374928
Principal Investigator:
Christopher Elder.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.